联系客服

000950 深市 重药控股


首页 公告 重药控股:半年度非经营性资金占用及其他关联资金往来情况汇总表

重药控股:半年度非经营性资金占用及其他关联资金往来情况汇总表

公告日期:2023-08-25

重药控股:半年度非经营性资金占用及其他关联资金往来情况汇总表 PDF查看PDF原文

        2023 年半年度非经营性资金占用及其他关联资金往来

                          情况汇总表

 编制单位:重药控股股份有限公司                                                                          单位:万元

                                                                          2023 年度占用累 2023 年度占用

                        资金占用方 占用方与上市公 上市公司核算 2023 年期初                              2023 年度偿还 2023 年期末占 占用形成

  非经营性资金占用                                                      计发生金额(不含资金的利息(如                                        占用性质
                          名称    司的关联关系  的会计科目  占用资金余额                              累计发生金额  用资金余额    原因

                                                                              利息)        有)

控股股东、实际控制人及其

      附属企业                                                                                                                              非经营性占用

          小计            -          -            -                                                                                            -

前控股股东、实际控制人及

      其附属企业                                                                                                                              非经营性占用

        小计              -          -            -                                                                                            -

 其他关联方及其附属企业                                                                                                                        非经营性占用

        小计              -          -            -                                                                                            -

        总计              -          -            -                                                                                            -


                                                                          2023 半年度往来 2023 半年度往 2023 半年度偿                            往来性质

 其他关联资金往                往来方与上市公司 上市公司核算 2023 年期初                                            2023年6月期末 往来形成

                资金往来方名称                                            累计发生金额(不 来资金的利息  还累计发生金                        (经营性往来、非
      来                          的关联关系    的会计科目  往来资金余额                                            往来资金余额  原因

                                                                              含利息)      (如有)        额                              经营性往来)

                重庆和平制药有 同受重庆化医控股

                                                  应收账款      14.23        214.93          0.00        191.38        37.78    销售货款  经营性往来
                    限公司    (集团)公司控制

                重庆生命科技与

                                同受重庆化医控股

                新材料产业集团                    应收账款      6.89          0.00          0.00          6.89          0.00    销售货款  经营性往来
                                (集团)公司控制

                  有限公司

                重庆化医宇丰实 同受重庆化医控股

控股股东、实际控                                  应收账款      153.29        93.50          0.00        107.79        139.00    销售货款  经营性往来
                业集团有限公司 (集团)公司控制

制人及其附属企业

                重庆科瑞制药(集 同受重庆化医控股

                                                  应收账款    1,273.14      1,687.58        0.00        1,019.29      1,941.44    销售货款  经营性往来
                团)有限公司  (集团)公司控制

                重庆千业健康管 同受重庆化医控股

                                                  应收账款    5,323.61      15,853.67        0.00        14,425.83      6,751.45    销售货款  经营性往来
                  理有限公司  (集团)公司控制

                重庆和平制药有 同受重庆化医控股

                                                  预付款项      74.18        273.00          0.00        331.69        15.49    预付货款  经营性往来
                    限公司    (集团)公司控制

                重庆科瑞制药(集 同受重庆化医控股  预付款项    3,687.66      2,493.41        0.00        1,660.89      4,520.18    预付货款  经营性往来

                                                                          2023 半年度往来 2023 半年度往 2023 半年度偿                            往来性质

 其他关联资金往                往来方与上市公司 上市公司核算 2023 年期初                                            2023年6月期末 往来形成

                资金往来方名称                                            累计发生金额(不 来资金的利息  还累计发生金                        (经营性往来、非
      来                          的关联关系    的会计科目  往来资金余额                                            往来资金余额  原因

                                                                              含利息)      (如有)        额                              经营性往来)

                团)有限公司  (集团)公司控制

                重庆千业健康管 同受重庆化医控股

                                                  预付款项      0.02          0.00          0.00          0.02          0.00    预付货款  经营性往来
                  理有限公司  (集团)公司控制

                重庆和平制药有 同受重庆化医控股                                                                                    保证金及

                                                  其他应收款      7.54        56.72          0.00          56.72          7.54                经营性往来
                    限公司    (集团)公司控制                                                                         
[点击查看PDF原文]